Nucgnex Lifesciences Private Limited, a active private limited company, was established on 18 May 2017 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24110PN2017PTC170493. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.83 M.
Formerly known as Nucgn Pharmaceuticals Private Limited. It upholds a compliant status. Employing 47 professional, Its leadership includes Pious Nitin Gandhi (Director), Sameer Shirish Gandhi (Director), Archana Nitin Gandhi (Director). Past directors included Pious Nitin Gandhi. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office 101, 1St Floor, Ecstasy - C Wing, Above Utsav Saree Center, Near City Pride, Kot, Hrud, Pune, Maharashtra, 411038.
U24110PN2017PTC170493
170493
18 May 2017
₹2.00 M
₹1.83 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Nucgnex Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pious Nitin Gandhi | Director | 01 Oct 2019 | Current |
| Sameer Shirish Gandhi | Director | 18 May 2017 | Current |
| Archana Nitin Gandhi | Director | 18 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nucgnex Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 144.06% increase. The company also saw a substantial improvement in profitability, with a 112.62% increase in profit. The company's net worth Soared by an impressive increase of 97.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Nucgnex Lifesciences had a public holding of 11.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2025 | Others | ₹1.00 M | Open |
| 23 Dec 2022 | Others | ₹6.00 M | Open |
Explore comprehensive loan charge details -
Nucgnex Lifesciences has a workforce of 47 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nucgnex Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucgnex Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 1.00 M with Charge ID 101087495 was registered on 17 Mar 2025. was documented.
The activity Nucgnex Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Nucgnex Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 6.00 M with Charge ID 100688918 was registered on 23 Dec 2022. was documented.
The activity Pious Nitin Gandhi was appointed as a Director was appointed as a Director on 01 Oct 2019 & has been associated with this company since 6 years 2 months . was completed.
Sameer Shirish Gandhi was appointed as a Director was appointed as a Director on 18 May 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
The CIN of Nucgnex Lifesciences Private Limited is U24110PN2017PTC170493.
Nucgnex Lifesciences Private Limited is headquartered at Office 101, 1St Floor, Ecstasy - C Wing, Above Utsav Saree Center, Near City Pride, Kot, Hrud, Pune, Maharashtra, 411038.
Nucgnex Lifesciences Private Limited was incorporated on 18 May 2017.
The current directors of Nucgnex Lifesciences Private Limited are
The primary industry of Nucgnex Lifesciences Private Limited is Manufacturing.
Nucgnex Lifesciences Private Limited is unlisted.
The authorized capital of Nucgnex Lifesciences Private Limited is ₹2.00 M, and the paid-up capital is ₹1.83 M.
The compliance status of Nucgnex Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX